Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Niagen Bioscience (NAGE) Shares Outstanding (Diluted Average): 2011-2024

Historic Shares Outstanding (Diluted Average) for Niagen Bioscience (NAGE) over the last 6 years, with Dec 2024 value amounting to $78.1 million.

  • Niagen Bioscience's Shares Outstanding (Diluted Average) rose 11.38% to $86.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was $86.6 million, marking a year-over-year increase of 11.38%. This contributed to the annual value of $78.1 million for FY2024, which is 4.19% up from last year.
  • According to the latest figures from FY2024, Niagen Bioscience's Shares Outstanding (Diluted Average) is $78.1 million, which was up 4.19% from $75.0 million recorded in FY2023.
  • In the past 5 years, Niagen Bioscience's Shares Outstanding (Diluted Average) registered a high of $78.1 million during FY2024, and its lowest value of $61.1 million during FY2020.
  • For the 3-year period, Niagen Bioscience's Shares Outstanding (Diluted Average) averaged around $74.3 million, with its median value being $75.0 million (2023).
  • Data for Niagen Bioscience's Shares Outstanding (Diluted Average) shows a peak YoY climbed of 10.02% (in 2021) over the last 5 years.
  • Niagen Bioscience's Shares Outstanding (Diluted Average) (Yearly) stood at $61.1 million in 2020, then increased by 10.02% to $67.2 million in 2021, then grew by 3.79% to $69.7 million in 2022, then grew by 7.54% to $75.0 million in 2023, then increased by 4.19% to $78.1 million in 2024.